Literature DB >> 32461307

Device-Associated Menstrual Toxic Shock Syndrome.

Patrick M Schlievert1, Catherine C Davis2.   

Abstract

In the 1980s, menstrual toxic shock syndrome (mTSS) became a household topic, particularly among mothers and their daughters. The research performed at the time, and for the first time, exposed the American public as well as the biomedical community, in a major way, to understanding disease progression and investigation. Those studies led to the identification of the cause, Staphylococcus aureus and the pyrogenic toxin superantigen TSS toxin 1 (TSST-1), and many of the risk factors, for example, tampon use. Those studies in turn led to TSS warning labels on the outside and inside of tampon boxes and, as important, uniform standards worldwide of tampon absorbency labeling. This review addresses our understanding of the development and conclusions related to mTSS and risk factors. We leave the final message that even though mTSS is not commonly in the news today, cases continue to occur. Additionally, S. aureus strains cycle in human populations in roughly 10-year intervals, possibly dependent on immune status. TSST-1-producing S. aureus bacteria appear to be reemerging, suggesting that physician awareness of this emergence and mTSS history should be heightened.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Staphylococcus aureuszzm321990; diaphragms; menstrual cups; tampons; toxic shock syndrome

Mesh:

Substances:

Year:  2020        PMID: 32461307      PMCID: PMC7254860          DOI: 10.1128/CMR.00032-19

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  232 in total

1.  Preparation of toxic shock syndrome toxin-1.

Authors:  D A Blomster-Hautamaa; P M Schlievert
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

2.  Effect of 17 beta-estradiol on immunoglobulin secretion by human tonsillar lymphocytes in vitro.

Authors:  M Evagelatou; J Farrant
Journal:  J Steroid Biochem Mol Biol       Date:  1994-02       Impact factor: 4.292

3.  Histocompatibility leukocyte antigens in patients with toxic-shock syndrome.

Authors:  R H Latham; B T Haslam; C Dewitt; M Skolnick; C B Smith
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

4.  Purpura fulminans due to Staphylococcus aureus.

Authors:  Gary R Kravitz; David J Dries; Marnie L Peterson; Patrick M Schlievert
Journal:  Clin Infect Dis       Date:  2005-03-02       Impact factor: 9.079

5.  Effect of Merocel vaginal sponge on growth of Staphylococcus aureus and production of toxic shock syndrome-associated toxins.

Authors:  P M Schlievert
Journal:  J Am Coll Surg       Date:  1996-07       Impact factor: 6.113

6.  Vaginal colonization with Staphylococcus aureus, positive for toxic-shock marker protein, and Escherichia coli in healthy women.

Authors:  A W Chow; K H Bartlett; R Percival-Smith; B J Morrison
Journal:  J Infect Dis       Date:  1984-07       Impact factor: 5.226

7.  Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome.

Authors:  J M Vergeront; S J Stolz; B A Crass; D B Nelson; J P Davis; M S Bergdoll
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

8.  Exfoliative dermatitis in an infant. Association with enterotoxin F-producing staphylococci.

Authors:  P J Chesney; R M Jaucian; R A McDonald; F A Kapral; M S Bergdoll
Journal:  Am J Dis Child       Date:  1983-09

9.  Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources.

Authors:  P F Bonventre; L Weckbach; J Staneck; P M Schlievert; M Thompson
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

Review 10.  Menstrual disorders in adolescence: investigation and management.

Authors:  Martha Hickey; Adam Balen
Journal:  Hum Reprod Update       Date:  2003 Sep-Oct       Impact factor: 15.610

View more
  9 in total

Review 1.  Medical Applications of Porous Biomaterials: Features of Porosity and Tissue-Specific Implications for Biocompatibility.

Authors:  Jamie L Hernandez; Kim A Woodrow
Journal:  Adv Healthc Mater       Date:  2022-02-19       Impact factor: 11.092

2.  Decolonization of Human Anterior Nares of Staphylococcus aureus with Use of a Glycerol Monolaurate Nonaqueous Gel.

Authors:  Patrick M Schlievert; Marnie L Peterson
Journal:  mSphere       Date:  2020-07-29       Impact factor: 4.389

3.  Staphylococcal Enterotoxin C Subtypes Are Differentially Associated with Human Infections and Immunobiological Activities.

Authors:  Olivia N Chuang-Smith; Patrick M Schlievert
Journal:  mSphere       Date:  2021-01-27       Impact factor: 4.389

4.  Pathogenicity and virulence of Staphylococcus aureus.

Authors:  Gordon Y C Cheung; Justin S Bae; Michael Otto
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

5.  Menstrual toxic shock syndrome.

Authors:  Takuya Seike; Taro Kanaya; Naoki Oishi
Journal:  CMAJ       Date:  2022-04-19       Impact factor: 8.262

6.  Pathogen Stimulation of Interleukin-8 from Human Vaginal Epithelial Cells through CD40.

Authors:  Patrick M Schlievert; Samuel H Kilgore; Andrea Benavides; Aloysius J Klingelhutz
Journal:  Microbiol Spectr       Date:  2022-03-17

7. 

Authors:  Takuya Seike; Taro Kanaya; Naoki Oishi
Journal:  CMAJ       Date:  2022-07-11       Impact factor: 16.859

8.  Staphylococcal TSST-1 Association with Eczema Herpeticum in Humans.

Authors:  Patrick M Schlievert; Richard J Roller; Samuel H Kilgore; Miguel Villarreal; Aloysius J Klingelhutz; Donald Y M Leung
Journal:  mSphere       Date:  2021-07-28       Impact factor: 4.389

Review 9.  Kawasaki syndrome: role of superantigens revisited.

Authors:  Donald Y M Leung; Patrick M Schlievert
Journal:  FEBS J       Date:  2020-08-24       Impact factor: 5.622

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.